ctDNA Monitoring in Patients With HCC and mCRC — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

ctDNA Monitoring in Patients With HCC and mCRC — Stella

Recruiting

Back to HCC - Hepatocellular Carcinoma trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Poland

Medical University of Warsaw, Warsaw, Masovian Voivodeship

Key details

Sponsor

Medical University of Warsaw

Collaborators

Medical Research Agency, Poland

Enrollment target

~300 participants

Started

January 2025

Primary completion

February 2027

Age range

18 Years – 75 Years

Last updated June 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov